France's Fluofarma and Roche Ink High-Content Assay Development Deal

The companies will develop miniaturized cell-based assays using high-throughput flow cytometry and computational models for hepatotoxicity testing.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.